Literature DB >> 20817855

Association of liver abnormalities with carcass grading performance and value.

T R Brown1, T E Lawrence.   

Abstract

The association of liver abnormalities with carcass grading performance, value, and dressed yield was evaluated on data from 76,191 carcasses housed in 2 databases. Liver abnormalities were assigned as follows: normal = edible liver; A- = 1 to 2 small abscesses or inactive scars; A = 1 to 2 large abscesses or multiple small abscesses; A+ = multiple large abscesses; A+AD = liver adhered to gastrointestinal tract or diaphragm or both; A+OP = open liver abscess; cirrhosis; distoma; and telangiectasis. Overall liver abnormality rates among both databases were A- = 5.0%, A = 2.6%, A+ = 2.0%, A+AD = 2.7%, A+OP = 1.4%, cirrhosis = 0.1%, distoma = 5.4%, and telangiectasis = 0.3%, with 80.5% of livers being normal. In database 1 (n = 3,936), BW was 33.3 kg less (P < 0.01) for carcasses with cirrhotic livers compared with carcasses with normal livers. Dressed yields for carcasses with A-, A+, A+AD, A+OP, and cirrhosis liver abnormalities were 0.28 to 0.89 percentage points less (P < 0.05) than carcasses with normal livers. In database 2 (n = 72,255), carcasses with A-, A+, A+AD, A+OP, cirrhosis, distoma, and telangiectasis liver abnormalities had reduced (P < 0.05) HCW and reduced (P < 0.05) LM area as compared with carcasses with a normal liver. Less (P < 0.05) 12th-rib subcutaneous fat was observed for carcasses with A-, A, A+, A+AD, A+OP, cirrhosis, and distoma abnormalities compared with carcasses with normal livers. Estimated KPH was less (P < 0.05) for carcasses with A-, A+, A+AD, A+OP, cirrhosis, and distoma abnormalities. Calculated yield grade was less (P < 0.05) for carcasses with A+AD, A+OP, cirrhosis, and distoma abnormalities compared with carcasses with normal livers. Marbling score of carcasses that had livers with A+AD or A+OP abscess scores or distoma was less (P < 0.05) than that of carcasses with normal livers. In database 2, market price per 45.35 kg did not differ (P = 0.32) among liver classification. Gross carcass value analyses indicated carcasses with A-, A, A+, A+AD, A+OP, cirrhosis, and distoma liver abnormalities were less valuable (P < 0.05) than carcasses with normal livers. These data delineate the association of liver abnormalities present at harvest with subsequent changes in carcass characteristics and ultimately lost carcass value.

Entities:  

Mesh:

Year:  2010        PMID: 20817855     DOI: 10.2527/jas.2010-3219

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  22 in total

1.  Investigation of tylosin in feed of feedlot cattle and effects on liver abscess prevalence, and fecal and soil microbiomes and resistomes1.

Authors:  Margaret D Weinroth; Jennifer N Martin; Enrique Doster; Ifigenia Geornaras; Jennifer K Parker; Clay R Carlson; Jessica L Metcalf; Paul S Morley; Keith E Belk
Journal:  J Anim Sci       Date:  2019-11-04       Impact factor: 3.159

2.  Effects of intermittent feeding of tylosin phosphate during the finishing period on feedlot performance, carcass characteristics, antimicrobial resistance, and incidence and severity of liver abscesses in steers.

Authors:  Hans Christian Müller; Cadra L Van Bibber-Krueger; Olanrewaju J Ogunrinu; Raghavendra G Amachawadi; H Morgan Scott; James S Drouillard
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

3.  Gross and histologic description of trematodosis in fetal and neonatal beef calves in North Dakota and Minnesota.

Authors:  Heidi L Pecoraro; Brianna L S Stenger; Laura E Rice; Brett T Webb
Journal:  J Vet Diagn Invest       Date:  2022-06-30       Impact factor: 1.569

4.  Effects of bismuth subsalicylate and encapsulated calcium-ammonium nitrate on feedlot beef cattle production.

Authors:  Sebastian E Mejia-Turcios; Andrea M Osorio-Doblado; Francine M Ciriaco; Phil M Urso; Rafael C Araujo; Dale R Woerner; Bradley J Johnson; Jose C B Dubeux; Jhones O Sarturi; Nicolas DiLorenzo; Darren D Henry
Journal:  J Anim Sci       Date:  2021-10-01       Impact factor: 3.338

5.  Effects of high-amylase corn on performance and carcass quality of finishing beef heifers.

Authors:  Lucas M Horton; Cadra L Van Bibber-Krueger; Hans C Müller; James S Drouillard
Journal:  J Anim Sci       Date:  2020-10-01       Impact factor: 3.159

6.  Genetic correlations between endo-parasite phenotypes and economically important traits in dairy and beef cattle.

Authors:  Alan J Twomey; Rebecca I Carroll; Michael L Doherty; Noel Byrne; David A Graham; Riona G Sayers; Astrid Blom; Donagh P Berry
Journal:  J Anim Sci       Date:  2018-03-06       Impact factor: 3.159

7.  Effect of alpha-tocopherol acetate and ascorbic acid on performance, carcass traits, and incidence and severity of liver abscesses in feedlot cattle.

Authors:  Hans C Müller; Cadra L van Bibber-Krueger; James S Drouillard
Journal:  J Anim Sci       Date:  2018-09-07       Impact factor: 3.159

8.  Using ruminally protected and nonprotected active dried yeast as alternatives to antibiotics in finishing beef steers: growth performance, carcass traits, blood metabolites, and fecal Escherichia coli.

Authors:  Tao Ran; Yizhao Z Shen; Atef M Saleem; Ousama AlZahal; Karen A Beauchemin; Wenzhu Z Yang
Journal:  J Anim Sci       Date:  2018-09-29       Impact factor: 3.159

9.  Defining syndromes using cattle meat inspection data for syndromic surveillance purposes: a statistical approach with the 2005-2010 data from ten French slaughterhouses.

Authors:  Céline Dupuy; Eric Morignat; Xavier Maugey; Jean-Luc Vinard; Pascal Hendrikx; Christian Ducrot; Didier Calavas; Emilie Gay
Journal:  BMC Vet Res       Date:  2013-04-30       Impact factor: 2.741

10.  Bacterial community analysis of purulent material from liver abscesses of crossbred cattle and Holstein steers fed finishing diets with or without tylosin.

Authors:  Raghavendra G Amachawadi; Wesley A Tom; Michael P Hays; Samodha C Fernando; Philip R Hardwidge; T G Nagaraja
Journal:  J Anim Sci       Date:  2021-04-01       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.